George Poste calls for the creation of international biobanks as part of research efforts on disease and drug-response biomarkers (Nature 469, 156-157; 2011) . As the director of Israel's biobank and a member of international biobank organizations, I must point out that this can only work if the use of genetic information is guaranteed to be non-discriminatory.
Pick sanitation over vaccination in Haiti
I have been investigating Haiti's water system since 2007 and strongly believe that the limited resources available to combat the country's cholera epidemic should be spent on sanitation and clean water, rather than on vaccination (Nature 469, 273-274; 2011) . Otherwise, the local geology and ecology will allow cholera and other waterborne pathogens to persist.
Haiti has a backbone of granitic igneous rocks near the border with the Dominican Republic, surrounded by sedimentary limestone and shale. Fissures in limestone give rise to shallow aquifers that are especially prone to contamination by water-borne pathogens.
The devastation of last year's earthquake in Haiti joined intractable problems of poverty, deforestation and the loss of its microbiotic ecosystem. Soil microorganisms that consume pathogens are integral to the macrobiotic ecosystem, and are a first line of defence against groundwater contamination. The loss of Haiti's soils and the beneficial organisms they host means that many shallow aquifers are now unprotected.
Pathogens that thrive in Haiti's warm groundwater are flushed out by heavy rains and hurricanes, helping them to spread and cause new disease outbreaks. This is why funds should be spent on long-term, sustainable and resilient water resources. For example, clinical trials often include dedicated biomarker studies, with a budget for collecting specimens and data -a facility that could contribute to shared repositories, serving both industry and the public at a modest additional public cost. Even if only a fraction of the more than four million subjects enrolled worldwide in interventional trials were to be captured, progress would be enormous.
From my work on biomarker detection at biotechnology company SDIX, and as a consultant on biobanking for public-health authorities, it is clear that this expansion could also advance public health, providing biomarkers to improve our understanding of risk factors associated with populationspecific diseases and helping us to tailor public-health initiatives.
Such a synergistic venture could significantly advance the field, but would require systematic encouragement from national health ministries, harmonization of protocols, integration of individual repositories into larger virtual networks, attention to ethical, legal and social implications, and respect for the need of private partners to retain certain intellectual-property rights. Klaus Lindpaintner Strategic Diagnostics (SDIX), USA. klindpaintner@sdix.com disseminated, regardless of merit, for rapid and public online criticism rather than slow, private peer review (Nature 469, 286-287; 2011) . For this to work, we must devise new ways to link widespread Internet discussions to and from an original paper.
Under current academic publishing models, one could easily miss substantive reactions to a paper that appear in other peer-reviewed journals. Even when a paper is retracted, research shows that this information is poorly disseminated and that the paper can continue to be cited widely and positively for years afterwards (K. M. Korpela Curr. Med. Res. Opin. 26, 843-847; 2010 
